Jipeng Wang

404 total citations
17 papers, 304 citations indexed

About

Jipeng Wang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jipeng Wang has authored 17 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jipeng Wang's work include RNA modifications and cancer (4 papers), Cancer-related molecular mechanisms research (4 papers) and MicroRNA in disease regulation (2 papers). Jipeng Wang is often cited by papers focused on RNA modifications and cancer (4 papers), Cancer-related molecular mechanisms research (4 papers) and MicroRNA in disease regulation (2 papers). Jipeng Wang collaborates with scholars based in China. Jipeng Wang's co-authors include Wei Chen, Li Zhang, Liang Yu, Wei Zhao, Biao Gu, Qingquan Wu, Lixin Wang, Yaqi Song, Jianhua Gong and Li He and has published in prestigious journals such as Applied Surface Science, Journal of Cellular Biochemistry and Oncotarget.

In The Last Decade

Jipeng Wang

16 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jipeng Wang China 11 214 137 42 30 25 17 304
Athanasios Pagkalos Greece 7 202 0.9× 102 0.7× 35 0.8× 62 2.1× 26 1.0× 10 308
Shasha Wu China 10 264 1.2× 153 1.1× 39 0.9× 39 1.3× 13 0.5× 20 329
Steffanus Pranoto Hallis South Korea 5 170 0.8× 108 0.8× 34 0.8× 41 1.4× 21 0.8× 9 269
Huayong Zhang China 12 238 1.1× 110 0.8× 49 1.2× 49 1.6× 19 0.8× 17 339
Changjiang Qin China 12 247 1.2× 132 1.0× 34 0.8× 65 2.2× 18 0.7× 17 335
Georgios Tsatsaris Greece 5 177 0.8× 78 0.6× 34 0.8× 71 2.4× 23 0.9× 13 296
Wang Li China 11 218 1.0× 119 0.9× 60 1.4× 50 1.7× 19 0.8× 37 348
Peizhi Fan China 10 163 0.8× 104 0.8× 22 0.5× 37 1.2× 21 0.8× 14 276
Ali Mahdavinezhad Iran 12 268 1.3× 215 1.6× 25 0.6× 55 1.8× 18 0.7× 33 427

Countries citing papers authored by Jipeng Wang

Since Specialization
Citations

This map shows the geographic impact of Jipeng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jipeng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jipeng Wang more than expected).

Fields of papers citing papers by Jipeng Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jipeng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jipeng Wang. The network helps show where Jipeng Wang may publish in the future.

Co-authorship network of co-authors of Jipeng Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Jipeng Wang. A scholar is included among the top collaborators of Jipeng Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jipeng Wang. Jipeng Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Li, Jie, Wenjing Shi, Linqing Yang, et al.. (2025). Oxidation-resistant boron-linked strengthened graphene-based composite. Applied Surface Science. 702. 163376–163376. 1 indexed citations
2.
Li, Yao, Pengfei Shi, Ting Ma, et al.. (2024). Microbiome-host interactions in the pathogenesis of acute exacerbation of chronic obstructive pulmonary disease. Frontiers in Cellular and Infection Microbiology. 14. 1386201–1386201. 1 indexed citations
3.
Li, Yao, Pengfei Shi, Ziwei Zhu, et al.. (2023). Analysis of sputum microbial flora in chronic obstructive pulmonary disease patients with different phenotypes during acute exacerbations. Microbial Pathogenesis. 184. 106335–106335. 7 indexed citations
4.
Wang, Jipeng, et al.. (2023). Knockdown of DLK4 inhibits non-small cell lung cancer tumor growth by downregulating CKS2. Open Life Sciences. 18(1). 20220720–20220720. 2 indexed citations
5.
Xia, Jingjing, Hong Li, Ruirui Zhang, & Jipeng Wang. (2023). Clinicopathological characteristics and prognosis of young patients aged ≤45 years old with non-small cell lung cancer. Open Medicine. 18(1). 20230684–20230684.
6.
Huang, Ziming, et al.. (2019). <p>Ubiquitin-specific peptidase 28 enhances STAT3 signaling and promotes cell growth in non-small-cell lung cancer</p>. OncoTargets and Therapy. Volume 12. 1603–1611. 20 indexed citations
7.
Xia, Jingjing, Hong Li, Ping Li, et al.. (2018). Clinicopathologic characteristics and EGFR mutations in lung cancer patients aged below 45 years. Current Problems in Cancer. 43(4). 363–370. 10 indexed citations
8.
Gu, Biao, et al.. (2018). The inhibitory effects of ginsenoside Rd on the human glioma U251 cells and its underlying mechanisms. Journal of Cellular Biochemistry. 120(3). 4444–4450. 19 indexed citations
9.
Chen, Wei, Wei Zhao, Sheng Chen, et al.. (2018). Expression and correlation of MALAT1 and SOX9 in non‐small cell lung cancer. The Clinical Respiratory Journal. 12(7). 2284–2291. 21 indexed citations
10.
Gu, Biao, et al.. (2018). microRNA‐383 regulates cell viability and apoptosis by mediating Wnt/β‐catenin signaling pathway in non–small cell lung cancer. Journal of Cellular Biochemistry. 120(5). 7918–7926. 23 indexed citations
11.
Gong, Jianhua, et al.. (2017). Increased Expression of Long Non-Coding RNA BCAR4 Is Predictive of Poor Prognosis in Patients with Non-Small Cell Lung Cancer. The Tohoku Journal of Experimental Medicine. 241(1). 29–34. 26 indexed citations
12.
Chen, Liang, et al.. (2017). Iron oxide magnetic nanoparticles combined with actein suppress non-small-cell lung cancer growth in a p53-dependent manner. International Journal of Nanomedicine. Volume 12. 7627–7651. 26 indexed citations
13.
Chen, Liang, et al.. (2017). Juglanin inhibits lung cancer by regulation of apoptosis, ROS and autophagy induction. Oncotarget. 8(55). 93878–93898. 32 indexed citations
14.
Chen, Wei, Wei Zhao, Li Zhang, et al.. (2017). MALAT1-miR-101-SOX9 feedback loop modulates the chemo-resistance of lung cancer cell to DDP via Wnt signaling pathway. Oncotarget. 8(55). 94317–94329. 64 indexed citations
15.
Yin, Li, Jipeng Wang, Tongpeng Xu, et al.. (2014). Downregulation of Kruppel-like factor 2 is associated with poor prognosis for nonsmall-cell lung cancer. Tumor Biology. 36(4). 3075–3084. 26 indexed citations
17.
Wang, Lixin, et al.. (2012). Association between the NBS1 Glu185Gln polymorphism and lung cancer risk: a systemic review and meta-analysis. Molecular Biology Reports. 40(3). 2711–2715. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026